The main competencies of Estonian biotechnology
Nowadays the main competences of Estonian biotechnology lie in medical biotechnology. Key areas in biotechnology research in Estonia are:
- Personalized medicine
- Stem cells
There are many advantages of the biotechnology sector in Estonia: the state supports R&D and innovation; the economic environment in Estonia is generally liberal and favourable towards entrepreneurship; biotechnology-related legislation is well-established and harmonized with EU legislation.
The sector offers a good scientific foundation and a large network of contacts, mainly with the Scandinavian region.
The benefits also come from good quality labour force – over the past few years there has been a trend of scientists repatriating; and approximately 500 graduates with relevant education enter the labour market every year.
There are approximately 100 Estonian companies, employing over field of biotechnology. Most of the companies are located in Tartu. Among the current tenants at Tartu Biotechnology Park, co-host of ScanBalt Forum 2017, are for example:
- OÜ TBD-Biodiscovery
- The Competence Centre on Health Technologies
- Qvalitas Arstikeskus AS
- Upstream OÜ
- OÜ Hansa Medical
- Estigen OÜ
- Probiotech OÜ
- Inbio OÜ
- OÜ Katriito
- Concise Systems OÜ
- GPE Globalpharma OÜ
This article is based on “Implementation plan of technology transfer in biotechnology”, Tartu Biotechnology Park 2014.
10 January 2023
Workshop #3: Reducing Pharmaceutical Residuals in the Baltic Sea Region – Comparative Analysis and Assessment of Possibilities | 9 February at 11:00-15:05 EET
4 January 2023
EDAH - a new European project ahead